Breaking News

inVentiv Health Names Clinical Ops EVP

December 18, 2012

Stansfield to lead development in Europe, Asia-Pac, and Latin America

Dr. Susan C. Stansfield has joined PharmaNet/i3, inVentiv Health’s clinical segment, as executive vice president of Clinical Operations for Phase II-IV Development in Europe, Middle East, and Africa (EMEA), Asia-Pacific, and Latin America. 
Dr. Stansfield has successfully held senior leadership positions at other global clinical research organizations and has a proven record of significantly enhancing clinical operations.
“This appointment demonstrates PharmaNet/i3’s commitment to enhancing support for regional operations in parallel to our global cross-functional project management team,” said Dr. Robert M. Reekie, chief operating officer, Phase II-IV Development. “We believe Susan is a great addition to our talented global team that is focused on delivering the best possible service to our clients.”
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus